These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34777867)

  • 1. Identification and expression analysis of antigenic sites of hepatitis C virus genotype 3a NS3 and NS5A genes of local isolate.
    Sabri S; Khan MI; Rafique S; Ali A; Khan MS
    Egypt Liver J; 2021; 11(1):17. PubMed ID: 34777867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis.
    Sabri S; Idrees M; Rafique S; Ali A; Iqbal M
    Int J Infect Dis; 2014 Aug; 25():38-44. PubMed ID: 24845365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a.
    Anwar MI; Iqbal M; Yousef MS; Rahman M
    Microb Cell Fact; 2013 Nov; 12():111. PubMed ID: 24238670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity assessment of hepatitis C virus NS3 protease and NS5A proteins expressed in TOPO cloning system.
    Alaee M; Rajabi P; Sharifi Z; Farajollahi MM
    J Microbiol Immunol Infect; 2014 Aug; 47(4):282-91. PubMed ID: 23040046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression of NS5a strong antigenic regions of hepatitis C virus in E.coli and detection of their antigenicity.
    Dou XG; Feng GH; Shi LL; Fields H
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):383-7. PubMed ID: 14607711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6.
    Ku KS; Chodavarapu RK; Martin R; Miller MD; Mo H; Svarovskaia ES
    J Clin Microbiol; 2016 Jul; 54(7):1835-1841. PubMed ID: 27147726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural prevalence of resistance-associated variants in hepatitis C virus NS5A in genotype 3a-infected people who inject drugs in Germany.
    Walker A; Siemann H; Groten S; Ross RS; Scherbaum N; Timm J
    J Clin Virol; 2015 Sep; 70():43-45. PubMed ID: 26305818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.
    Schnell G; Krishnan P; Tripathi R; Beyer J; Reisch T; Irvin M; Dekhtyar T; Lu L; Ng TI; Xie W; Pilot-Matias T; Collins C
    PLoS One; 2018; 13(10):e0205186. PubMed ID: 30286205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection.
    Sillanpää M; Melén K; Porkka P; Fagerlund R; Nevalainen K; Lappalainen M; Julkunen I
    Virol J; 2009 Jun; 6():84. PubMed ID: 19549310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
    El-Shamy A; Shindo M; Shoji I; Deng L; Okuno T; Hotta H
    Hepatology; 2013 Aug; 58(2):555-63. PubMed ID: 23281009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient.
    Provazzi PJ; Mukherjee S; Hanson AM; Nogueira ML; Carneiro BM; Frick DN; Rahal P
    PLoS One; 2015; 10(12):e0144638. PubMed ID: 26658750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
    Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
    J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and fluorescence analysis of HCV non-structural proteins NS3, NS3-4A and NS4A of genotype 3a.
    Javed F; Manzoor S; Khattak AA; Imran M; Parvaiz F; Ashraf J; Tariq H; Bhatti S
    Acta Virol; 2015 Sep; 59(3):284-94. PubMed ID: 26435152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients.
    Sadri M; Farajollahi MM; Sharifi Z
    Iran J Basic Med Sci; 2015 Feb; 18(2):159-63. PubMed ID: 25810890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice.
    Shi N; Hiraga N; Imamura M; Hayes CN; Zhang Y; Kosaka K; Okazaki A; Murakami E; Tsuge M; Abe H; Aikata H; Takahashi S; Ochi H; Tateno-Mukaidani C; Yoshizato K; Matsui H; Kanai A; Inaba T; McPhee F; Gao M; Chayama K
    Gut; 2013 Jul; 62(7):1055-61. PubMed ID: 23322441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine.
    Ikram A; Obaid A; Awan FM; Hanif R; Naz A; Paracha RZ; Ali A; Janjua HA
    Antiviral Res; 2017 Jan; 137():112-124. PubMed ID: 27984060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of HCV genotype 1 resistance-associated substitutions in NS5A, NS3 and NS5B pre-and post-treatment with 12 weeks of daclatasvir, asunaprevir and beclabuvir.
    McPhee F; Hernandez D; Zhou N; Ueland J; Yu F; Vellucci V; Huang X; Wang X; Ishikawa H; Karino Y; Kumada H
    Antivir Ther; 2018; 23(1):53-66. PubMed ID: 28594332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.